Last $8.84 USD
Change Today -0.62 / -6.55%
Volume 1.6M
IMGN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:20 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James J. O'Leary M.D.

Former Chief Medical Officer and Vice President, ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

50$1,392,803
As of Fiscal Year 2014

Background*

Dr. James J. O'Leary, also known as Jim, M.D. served as the Chief Medical Officer and Vice President of Immunogen, Inc. from November 10, 2008 to October 2014. Dr. O'Leary led the clinical development of ImmunoGen's product candidates. He has all the skills to effectively lead the development of clinical-stage compounds and provide strategic input on earlier-stage programs. He has experience in all phases of product development - from preclinical to registration - and ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$382,100
Total Annual Compensation$382,100

Stock Options*

All Other Compensation$8,184
Exercised Options35,000
Exercised Options Value$521,423
Exercisable Options217,000
Exercisable Options Value$564,390
Unexercisable Options155,000
Total Value of Options$1,085,813
Total Number of Options407,000

Total Compensation*

Total Annual Cash Compensation$515,326
Total Short Term Compensation$382,100
Other Long Term Compensation$8,184
Total Calculated Compensation$1,392,803
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $8.84 USD -0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.